Clinical Trial of an Omicron-Targeting Vaccine Is Ready to Begin
As Americans’ COVID-19 fatigue continues to grow, Pfizer announced it will begin a clinical trial on a COVID-19 vaccine designed to target the highly transmissible Omicron variant of SARS-CoV-2. Pfizer’s original two-dose COVID-19 vaccine…